Canaimex-Wuhan Pharmaceutical Co, LTD is founded by Canaimex, Inc in Canada and registered in East-lake Hi-Tech Development Zone Wuhan. With support of professional team and parent company's international marketing channel,Canaimex-Wuhan integrates research, development, production and international sales, specializing in drug research & Development, the advanced drug intermediates and chemical technology development.
　With a fully support from parent company in marketing/technology information,Canaimex-Wuhan will focus on pharmaceutical technology innovation, new advanced intermediates development, process research & development.

Company Strength：
　　*International Marketing Network: Canaimex in Canada has established international marketing channel. With over 400 pharmaceutical companies as its regular customers and three distributors covering Japan, Europe, North America, Canaimex ,Inc. in Canada and Canaimex-Wuhan are able to introduce new products and market products worldwide rapidly.
　 *Capability in Organic Synthesis and Product Development: The educated and experienced scientists from giant pharmaceutical companies have capability to develop new products and process in short time.
　 *Excellent Management System: Based on international standard management model and Canaimex' management system,Canaimex-Wuhan has established an efficient management system which emphases on employee's creativity and market.
　 *Market and Technology Information: With a fully support from Canaimex in Canada, Canaimex-Wuhan is able to access the updated international marketing information and technology information.

Strategy：
　 Technology Innovation: Canaimex-Wuhan will focus on new technology, new process, such as chiral catalysts, enzyme catalysis, biochemical reaction in development and manufacture pharmaceutical intermediates, drugs and other fine chemicals.
　 *Product Development: AstaTech-Chengdu will develop new process to manufacture high value drugs and drug intermediates to supply worldwide market. Design and produce new intermediates for drug research.
　 *International Market Development: With the support from parent company in USA, AstaTech-Chengdu will market the products and services worldwide by international trade show, internet and advertisement.

Main Equipment Capacity：
　　*Volume of Reaction Kettle: 50-5000 GL
　　*Temperature: Meeting the chemical reaction at -30-350 ℃
　　*Vacuum of vacuumized distilling equipment: Reaching 1-5 mm Hg
　　*Pressure of pressure kettle: Meeting the demand for the reaction at below 15 MPa
　　*Volume of two-cone rotating vacuum drier: 2,000 GL

Special Techniques：
　　*Oxidizing and reducing reactions
　　*Nitrifying and halogenating reactions
　　*Alkylation Reaction
　　*catalyzing hydrogenation reaction
　　*Diazo and coupling reaction
　　*Synthetic reaction of organic electrochemistry

Business Scope：
　　*Customer Synthesis and Manufacture
　　With a fully support from parent company in technical information search and experienced professional team, Canaimex-Wuhan is able to provide the customer synthesis and manufacture in good quality and reasonable price.
　　*Product Development
　　Canaimex-Wuhan will focus on new process research of patent/off patent drugs, new drug intermediates, agrochemical and pharmaceutical products.
　　*Technology Transfer
　　Over hundred processes for fine chemical and drug intermediates have been accumulated, Canaimex and Canaimex-Wuhan is willing to transfer these technology to partners and provide international marketing/sales services.
　　*Distributors and International Marketing Service
　　Collaborating with parent company in Canada,Canaimex-Wuhan can provide international market information and act as distributor in international marketing/sales for high value fine chemicals/pharmaceutical intermediates.
　　*Import & Export
　　Canaimex-Wuhan has authority in import & export for fine chemicals and drug intermediates.